-
Our Newest Pharmacologic Class for Treatment of Diabetes: SGLT2 Inhibitors
-
Insomnia is a common complaint among adults and it is well recognized that mental performance can be impaired by poor sleep. Both difficulty falling asleep and trouble staying asleep have been associated with poor cognitive function in cross-sectional elderly cohorts.
-
-
A new topical agent is available for the treatment of actinic keratosis (AK). Ingenol mebutate is a macrocyclic diterpene ester found in the sap of Euphorbia peplus, a common plant found in Africa, Europe, and Asia.
-
Regardless of the caffeine status, coffee intake was associated with reduced risk of type 2 diabetes while sugar-sweetened beverages were associated with a higher risk.
-
-
In this paper, the authors report the results of a study that examined the impact of yoga training on patients with paroxysmal atrial fibrillation (AF). The authors enrolled 101 patients with paroxysmal AF who were on a stable medical regimen.
-
Chelation therapy for cardiovascular disease; statins and kidney injuries; chlorthalidone for hypertension; and FDA actions.
-
The prevalence and natural history of aortic stenosis (AS) are well known. However, there is a paucity of data about the natural history of combined AS and aortic regurgitation (AR). AS and AR confer differing types of stress on the left ventricle, and it stands to reason that the combination may result in worse outcomes than either AS or AR alone.
-
Newer biomarkers such as B-type natriuretic peptide (BNP) and high-sensitive troponins have been shown to be of prognostic value in patients with cardiovascular disease. These investigators from central Europe sought to determine if they were of value in risk stratification for non-cardiac surgery.